Aspirin may leads to lower all cardiovascular events compared with placebo (low certainty).
CCBs showed no clear difference in all‐cause mortality compared with diuretic (moderate certainty).
CCBs may leads to lower cardiovascular mortality compared with β‐blocker (low certainty).
CCBs showed no clear difference in all‐cause mortality compared with ACE inhibitor (low certainty).
CCBs showed no clear difference in myocardial infarction compared with ACE inhibitor (low certainty).
CCBs may leads to lower stroke compared with ACE inhibitor (low certainty).
CCBs may leads to higher congestive heart failure compared with ACE inhibitor (low certainty).
CCBs showed no clear difference in cardiovascular mortality compared with ACE inhibitor (moderate certainty).
CCBs showed no clear difference in all‐cause mortality compared with ARB (moderate certainty).
CCBs probably leads to lower myocardial infarction compared with ARB (moderate certainty).
CCBs showed no clear difference in stroke compared with ARB (moderate certainty).
CCBs may leads to higher congestive heart failure compared with ARB (low certainty).
CCBs showed no clear difference in myocardial infarction compared with diuretic (moderate certainty).
CCBs showed no clear difference in cardiovascular mortality compared with ARB (moderate certainty).
CCBs showed no clear difference in stroke compared with diuretic (moderate certainty).
CCBs probably leads to higher congestive heart failure compared with diuretic (moderate certainty).
CCBs showed no clear difference in cardiovascular mortality compared with diuretic (moderate certainty).
CCBs showed no clear difference in all‐cause mortality compared with β‐blocker (moderate certainty).
CCBs showed no clear difference in myocardial infarction compared with β‐blocker (moderate certainty).
CCBs probably leads to lower stroke compared with β‐blocker (moderate certainty).